SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)Business Wire • Monday
SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-FBusiness Wire • 04/29/24
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender OfferBusiness Wire • 01/18/24
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 InjectionBusiness Wire • 09/11/23
SVA DEADLINE TODAY: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of Its Officers - SVANewsfile Corp • 10/17/22
SVA Deadline Notice: ROSEN, Top Ranked Investor Counsel, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVANewsfile Corp • 10/13/22
SVA FINAL DEADLINE MONDAY: ROSEN, A LEADING NATIONAL FIRM, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVAPRNewsWire • 10/11/22
SVA FINAL DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers – SVABusiness Wire • 10/10/22
ROSEN, A Leading Law Firm, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVANewsfile Corp • 10/05/22
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVAPRNewsWire • 10/04/22
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVAPRNewsWire • 10/01/22
ROSEN, Top Ranked Investor Counsel, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVANewsfile Corp • 09/27/22
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVAPRNewsWire • 09/23/22
ROSEN, Top Ranked Investor Counsel, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVANewsfile Corp • 09/19/22
ROSEN, Leading Investor Counsel, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVANewsfile Corp • 09/15/22
ROSEN, A Leading Law Firm, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVANewsfile Corp • 09/12/22
